IL‐12/15/18‐preactivated NK cells suppress GvHD in a mouse model of mismatched hematopoietic cell transplantation-Reference-Cited by-同舟云学术

IL‐12/15/18‐preactivated NK cells suppress GvHD in a mouse model of mismatched hematopoietic cell transplantation

Published:2015-04-17 Issue:6 Volume:45 Page:1727-1735
ISSN:0014-2980
Container-title:European Journal of Immunology
language:en
Short-container-title:Eur. J. Immunol.

Author:

Hüber Christian M.¹,Doisne Jean‐Marc¹,Colucci Francesco¹

Affiliation:

1. Department of Obstetrics and Gynaecology University of Cambridge School of Clinical Medicine, National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre Cambridge UK

Funder

Wellcome Trust

Leukaemia and Lymphoma Research

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/eji.201445200

Reference22 articles.

1. Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation.

2. Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic Transplants

3. Cytotoxicity of CD56bright NK Cells towards Autologous Activated CD4+ T Cells Is Mediated through NKG2D, LFA-1 and TRAIL and Dampened via CD94/NKG2A

4. Activated, But Not Resting, T Cells Can Be Recognized and Killed by Syngeneic NK Cells

5. NK cells mediate reduction of GVHD by inhibiting activated, alloreactive T cells while retaining GVT effects

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural killer cell memory: challenges and opportunities for cancer immunotherapy;Cancer Biology & Therapy;2024-07-10

2. Optimizing interleukin-6 and 8 expression, clarification and purification in plant cell packs and plants for application in advanced therapy medicinal products and cellular agriculture;Journal of Biotechnology;2024-07

3. Cytokine‐Induced Memory‐Like NK Cells: Emerging strategy for AML immunotherapy;Biomedicine & Pharmacotherapy;2023-12

4. Beyond αβ T cells: NK, iNKT, and γδT cell biology in leukemic patients and potential for off-the-shelf adoptive cell therapies for AML;Frontiers in Immunology;2023-08-15

5. Impact of Early Natural Killer Cell Reconstitution on the Outcomes of T Cell-Replete Allogeneic Hematopoietic Stem Cell Transplantation;Journal of Inflammation Research;2023-07